Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	139.52	59.85	24.99
Graham Fair Price	-34.60	12.65	19.34
PEG	228.08	-0.36	0.11
Price/Book	8.91	1.61	1.48
Price/Cash Flow	7600.78	-1767.97	22.96
Prices/Earnings	162.08	21.04	8.03
Price/Sales	167.56	14.91	5.57
Price/FCF	7600.78	-1767.97	22.96
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	11.84	0.35	0.32
Operating Margin	-14.20	0.17	0.20
ROA	-58.85	0.01	0.03
ROE	0.05	0.02	-58.44
ROIC	0.04	0.01	-65.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.50	-82.90
Dividends QOQ	0.41	-0.24	-40.70
EBIT QOQ	0.60	-0.65	7.99
EPS QOQ	0.73	-0.58	-20.12
FCF QOQ	3.23	-1.01	-68.56
Revenue QOQ	0.54	-0.59	9.10
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	131.43	365.48	178.08
Days Sales Outstanding (DSO)	159.68	363.18	127.45
Inventory Turnover	0.68	0.25	-64.04
Debt/Capitalization	0.22	0.25	11.59
Quick Ratio	1.74	1.62	-6.91
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.99	19.27	1.45
Cash	7.64	7.06	-7.52
Capex	-0.57	-0.23	59.39
Free Cash Flow	1.22	-0.02	-98.57
Revenue	5.04	2.08	-58.70
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.33	2.42	3.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.93	1.23	31.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating